PAGLIARI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 456
EU - Europa 136
AS - Asia 104
Totale 696
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 454
IT - Italia 81
SG - Singapore 53
CN - Cina 39
FI - Finlandia 11
SE - Svezia 11
FR - Francia 10
DE - Germania 9
GB - Regno Unito 8
JP - Giappone 4
IN - India 3
CA - Canada 2
HK - Hong Kong 2
UA - Ucraina 2
AT - Austria 1
ID - Indonesia 1
IE - Irlanda 1
KR - Corea 1
LV - Lettonia 1
NL - Olanda 1
PK - Pakistan 1
Totale 696
Salva come PNG Salva come JPEG
Città #
Chandler 87
Fairfield 82
Ashburn 43
Singapore 42
Cambridge 32
Woodbridge 24
Padova 19
Des Moines 17
San Diego 15
Wilmington 14
Houston 12
Medford 10
Princeton 10
Beijing 9
Helsinki 8
Legnaro 8
Quartu Sant'Elena 7
Seattle 7
Ann Arbor 6
Cagliari 6
Santa Clara 6
Turin 6
Frankfurt am Main 4
Milan 4
Nanjing 3
Rimini 3
Boardman 2
Conegliano 2
Duncan 2
Florence 2
Hefei 2
Hong Kong 2
Lappeenranta 2
Limbiate 2
Los Angeles 2
Matsudo 2
New Bedfont 2
New York 2
Tianjin 2
Tokyo 2
Toronto 2
Wuhan 2
Amsterdam 1
Arezzo 1
Borås 1
Changsha 1
Dallas 1
Dublin 1
Guangzhou 1
Hangzhou 1
Hebei 1
Hounslow 1
Incheon 1
Jakarta 1
Kharkiv 1
London 1
Mammelzen 1
Milton Keynes 1
Modugno 1
Montichiari 1
Mountain View 1
Nanchang 1
Norwalk 1
Ogden 1
Phoenix 1
Pontecagnano 1
Prescot 1
Pune 1
Riga 1
Rome 1
Roxbury 1
Shenyang 1
Tombolo 1
Washington 1
Totale 548
Salva come PNG Salva come JPEG
Nome #
Helicobacter pylori affects the antigen presentation activity of macrophages modulating the expression of the immune receptor CD300E through miR-4270 104
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity 82
Helicobacter pylori affects the antigen presentation ability of macrophages modulating the expression of the immune receptor CD300E through miR-4270 78
Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies 76
Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers 75
Helicobacter pylori antigenic Lpp20 is a structural homologue of Tipα and promotes epithelial-mesenchymal transition 61
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: Comparison with neutralization titers 48
Neutralizing antibody titers six months after Comirnaty vaccination: kinetics and comparison with SARS-CoV-2 immunoassays 45
Asymptomatic and Mild SARS-CoV-2 Infections Elicit Lower Immune Activation and Higher Specific Neutralizing Antibodies in Children Than in Adults 40
SARS-CoV-2 infection and replication in human gastric organoids 29
SARS-CoV-2 neutralizing antibodies after one or two doses of Comirnaty (BNT162b2, BioNTech/Pfizer): Kinetics and comparison with chemiluminescent assays 28
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection 11
Host Response of Syrian Hamster to SARS-CoV-2 Infection including Differences with Humans and between Sexes 9
Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies 8
SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient 7
Stronger and durable SARS-CoV-2 immune response to mRNA vaccines in 5–11 years old children with prior COVID-19 7
Interplay of Modified Sialic Acid Inhibitors and the Human Parainfluenza Virus 1 Hemagglutinin-Neuraminidase Active Site 6
Design, Synthesis, and Antiviral Evaluation of Sialic Acid Derivatives as Inhibitors of Newcastle Disease Virus Hemagglutinin-Neuraminidase: A Translational Study on Human Parainfluenza Viruses 4
Totale 718
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.195
article - articoli 3.841
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.036
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028 0 0 0 1 3 1 7 2 3 8 2 1
2020/202185 0 1 0 0 1 0 8 4 8 10 5 48
2021/2022175 8 12 23 3 2 30 30 3 8 3 19 34
2022/2023154 31 20 6 24 16 24 2 8 13 1 8 1
2023/2024162 8 11 19 14 15 16 11 16 10 17 9 16
2024/202582 7 37 38 0 0 0 0 0 0 0 0 0
Totale 718